Corticotropin-releasing hormone increases prostaglandin F2α activity on human myometrium in vitro
- 1 July 1994
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 171 (1) , 126-131
- https://doi.org/10.1016/0002-9378(94)90457-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissuesJournal of Clinical Endocrinology & Metabolism, 1993
- Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancyJournal of Clinical Endocrinology & Metabolism, 1993
- Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotropin-releasing factor (CRF) and CRF messenger ribonucleic acidJournal of Clinical Endocrinology & Metabolism, 1992
- The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF.Proceedings of the National Academy of Sciences, 1992
- 2. Corticotrophin-releasing hormone production by the placenta and fetal membranesPlacenta, 1991
- The corticotropin releasing hormone gene is expressed in human placentaBiochemical and Biophysical Research Communications, 1987
- Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placentaNature, 1987
- Plasma Corticotropin-Releasing Hormone Concentrations During Pregnancy and Parturition*Journal of Clinical Endocrinology & Metabolism, 1987
- Immunoreactive Corticotropin-Releasing Hormone in Human Plasma During Pregnancy, Labor, and Delivery*Journal of Clinical Endocrinology & Metabolism, 1987
- High Levels of Corticotropin-Releasing Hormone Immunoactivity in Maternal and Fetal Plasma during Pregnancy*Journal of Clinical Endocrinology & Metabolism, 1986